Alternate day fasting (ADF) with a low-fat (LF) diet increases low-density lipoprotein (LDL) particle size. Whether these beneficial effects can be reproduced by a high-fat (HF) ADF diet is unclear. This study compared an ADF-HF to an ADF-LF diet on plasma lipids, LDL size and high-density lipoprotein (HDL) size. Thirty-five obese subjects were randomized to an ADF-HF or ADF-LF diet for 10 weeks. Body weight decreased (Po0.0001) by 4.3±1.0 kg (4.8±1.1%) and 3.7±0.7 kg (4.2±0.8%) in the ADF-HF and ADF-LF group, respectively. LDL cholesterol was reduced (Po0.0001) by 19 ± 8 mg/dl (18 ± 5%) by ADF-HF and 28 ± 7 mg/dl (25 ± 3%) by ADF-LF. LDL particle size increased (Po0.005) by 3 ± 1 Å in both groups. The proportion of small LDL particles decreased (Po0.005) by 8±2% and 11±3% in the ADF-HF and ADF-LF groups, respectively. HDL cholesterol and HDL size remained unchanged. Thus, our results suggest that the ADF-HF diet is equally as effective as the ADF-LF diet in improving LDL particle size and distribution. Keywords: alternate day fasting; calorie restriction; dietary fat; weight loss; LDL particle size; HDL particle size INTRODUCTION Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particle size are important predictors of cardiovascular events and progression.
INTRODUCTION
Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particle size are important predictors of cardiovascular events and progression. 1 Small LDL particles are detrimental to vascular health due to an increased propensity for oxidation. 1 Small HDL particles, on the other hand, may increase coronary heart disease (CHD) risk by altering the activity of lipases involved with the maturation and transformation of lipoproteins. 1 Dietary restriction regimens have shown promise for increasing LDL and HDL particle size. Alternate day fasting (ADF) is one particularly effective diet regimen that has helped obese individuals to improve LDL and HDL size and distribution. 2, 3 ADF regimens include a 'feed day', where food is consumed ad-libitum over 24 h (which generally equates to 125% of energy needs consumed 2, 3 ), followed by a 'fast day', where intake is limited to 25% of the individual's energy needs over 24 h. Two recent clinical trials of ADF, with a low-fat (LF) background diet, demonstrate that LDL and HDL particle size increased, whereas the proportion of small particles decreased, after 8-12 weeks of treatment. 2, 3 These favorable changes were accompanied by LDL cholesterol and triglyceride reductions of 10-25% and 30-40%, respectively, from baseline. 2, 3 Although ADF-LF diets have shown promising results, recent data from the National Health and Nutrition Examination Survey (NHANES) suggest that the average middle aged American consumes 35-45% of their daily calories as dietary fat. 4 In view of the high-fat content of the American diet, it is important to investigate whether the improvements in LDL and HDL particle size by ADF can be reproduced if a high-fat (HF) background diet is used in place of a LF diet. Accordingly, the objective of the present study was to compare the effects of an ADF-HF diet to that of an ADF-LF diet on HDL and LDL particle size and distribution in obese adults.
MATERIALS AND METHODS

Subject selection
Obese subjects were recruited from the Chicago area by advertisements. Key inclusion criteria were as follows: females, aged 25-65 years, body mass index (BMI) between 30 and 39.9 kg/m 2 , weight stable, previously sedentary and no history of cardiovascular disease. Eligible subjects were randomized by a stratified random sample based on BMI and age to either the ADF-HF group or the ADF-LF group. The experimental protocol was approved by the Office for the Protection of Research Subjects at the University of Illinois, Chicago, and all volunteers gave written informed consent.
Study design and diet protocol
The trial ran for 10 weeks and involved a 2-week baseline weight maintenance period followed by an 8-week weight loss period. During the baseline period, subjects in the ADF-HF group consumed 100% of their energy needs as the HF diet, whereas subjects in the ADF-LF group consumed 100% of their energy needs as the LF diet. During the 8-week weight loss period, subjects consumed either the HF or LF diet while undergoing ADF. The ADF protocol involved consuming 25% of energy needs on the fast day (24 h period), and 125% of energy needs on the feed day (24 h period). Fast day meals were consumed between 1200 and 0200 hours. All meals were provided during the entire 10-week trial. Energy requirements were calculated using the Mifflin equation. 5 Macronutrient distributions of the two diets were as follows: ADF-HF (45% fat, 40% carbohydrate and 15% protein), ADF-LF (25% fat, 60% carbohydrate and 15% protein). Fat content of the diets were as follows: ADF-HF (14% saturated fat, 20% monounsaturated fat, 11% polyunsaturated fat and 0% trans fat), and ADF-LF (6% saturated fat, 13% monounsaturated fat, 6% polyunsaturated fat and 0% trans fat). Body weight was measured weekly using a balance beam scale (HealthOMeter; Sunbeam Products, Boca Raton, FL, USA). Fat mass and fat-free mass were assessed by dual energy X-ray absorptiometry at weeks 1, 3 and 10 (QDR 4500 W, Hologic, Arlington, MA, USA).
Plasma lipids and particle size determination
Twelve-hour fasting blood samples were collected at week 1, 3 and 10. Plasma total cholesterol, direct LDL cholesterol, HDL cholesterol and triglyceride concentrations were measured in duplicate using enzymatic kits (Biovision Inc., Moutainview, CA, USA). LDL and HDL particle size were measured by linear polyacrylamide gel electrophoresis (Quantimetrix Lipoprint System, Redondo Beach, CA, USA), as described previously. 6 Lipoware computer software (Quantimetrix, Redondo Beach, CA, USA) was then used to divide LDL into small (o255 Å), medium (255-260 Å) and large (4260 Å) particles, and HDL into small (o73 Å), medium (73-88 Å) and large (488 Å) particles. 6 The interassay coefficients of variation for total cholesterol, HDL cholesterol, triacylglycerol concentrations and LDL particle size were 2.9%, 1.8%, 2.4%, and 1.9%, respectively.
Statistics
Results are presented as mean ± s.e.m. Normality was assessed by the Kolmogorov-Smirnov test. No variables were found to be not normal. An independent samples t-test was used to test baseline differences between groups. Mixed model analysis of variance time Â treatment was performed (taking time as the within-subject factor and diet as the between-subject factor) to assess differences between groups over the course of the study. Post-hoc analyses were performed using the Tukey test. Differences were considered significant at Po0.05. All data were analyzed using SPSS software (version 20.0, SPSS Inc, Chicago, IL, USA).
RESULTS
Baseline characteristics and weight loss
Thirty-five subjects began the study (ADF-HF: n ¼ 17, ADF-LF: n ¼ 18). Two subjects dropped out of the ADF-HF group, and one subject dropped out of the ADF-LF group due to an inability to comply with the diet. Baseline body weight (ADF-HF: 91.5 ± 2.6 kg, ADF-LF: 91.5 ± 2.9 kg), percent body fat (ADF-HF: 48. 
Plasma lipids
Total cholesterol decreased by 13 ± 2 and 16 ± 2% (Po0.0001) in the ADF-HF and ADF-LF groups, respectively (Table 1) . LDL cholesterol concentrations were also reduced by 18 ± 5 and 25 ± 3% (Po0.0001) by the ADF-HF and ADF-LF diet, respectively. Triglycerides decreased by 14±5 and 14±4% (Po0.001) in the ADF-HF and ADF-LF groups, respectively. HDL cholesterol did not change in either group. There were no between-group differences for any plasma lipid parameter.
LDL and HDL particle size Peak LDL particle size increased by 3 ± 1 Å (Po0.005) in both groups ( Table 2 ). The proportion of large LDL particles increased by 6±2% and 3±1% (Po0.005) in the ADF-HF and ADF-LF groups, respectively, while the proportion of small particles decreased (Po0.005) by 8 ± 2% and 11 ± 3% (Po0.005) in the ADF-HF and ADF-LF groups, respectively. Medium LDL particles increased by 8±3% (Po0.005) in the ADF-LF group only. HDL particle size was not changed in either group.
DISCUSSION
This study is the first to show that ADF with a HF background diet (45% fat) elicits the same beneficial effects on LDL particle size as ADF with an LF diet (25% fat). Specifically, the ADF-HF diet was as effective as the ADF-LF intervention at increasing LDL particle size, elevating the proportion of large LDL particles and decreasing the proportion of small LDL particles. HDL particle size and distribution were not affected by either diet.
These findings are in concordance with previous studies examining the effects of calorie restriction-high fat (CR-HF) diets on LDL particle size. 1, 7 For instance, Krauss et al. 1 demonstrated that peak LDL particle size was increased to a similar extent by a CR-HF (5 ± 1 Å) and a CR-LF intervention (3 ± 1 Å), after 5 weeks of treatment. Similarly, in a study by Hays et al., 7 obese individuals observed increases in LDL particle size (4±1 Å) after 6 weeks on an energy restriction HF diet (40% fat). Recent evidence indicates that diets high in saturated fat and cholesterol cause progressive elevations in LDL particle size because of an increase in cholesterol ester content. 8 As for HDL particle size, the present study indicates that ADF-HF and ADF-LF diets have no effect on this lipid parameter. This is not surprising as HDL particle size is rarely improved through changing dietary patterns alone. Although one recent study demonstrated increases in HDL particle size (2±1 Å) after 6 weeks of a CR-HF diet (40% fat), 1 others have shown no effect. 9 To date, the most effective intervention to improve HDL size and distribution is endurance exercise training. 10 Exercise-induced mechanisms for this change may involve increases in lipoprotein lipase activity and lecithin cholesterol acyl-transferase activity.
11 As such, it is possible that if this intervention were combined with exercise, beneficial changes in HDL size would be noted.
This study is limited in that the sample size of the two intervention groups (n ¼ 15-17) was quite small. This may have limited our ability to detect significant differences in HDL particle size. Our study is also limited in that we used polyacrylamide gel electrophoresis, instead of a more robust measure, such as nuclear magnetic resonance. A key strength of our study is the controlled feeding component. As we provided all the food, we can be certain that the dietary fat intake of the subjects was close to 45% in the HF group and 25% in the LF group. Taken together, ADF can improve certain CHD risk factors, such as LDL particle size, regardless of dietary fat content. Whether these effects persist long-term warrants furthur investigation. From a clinical standpoint, these findings suggest that individuals will not need to change the types of foods they eat, only the pattern of food consumption, to experience the cardio-protective benefits of ADF.
